Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 50147 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 55323 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 67289 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 90423 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 102225 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 104346 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 105018 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 105663 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 110041 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 113159 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 113644 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 130361 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 157842 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 169031 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 313116 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 336127 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 380630 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 513459 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 539977 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 555471 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 564685 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 567397 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 571262 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 599029 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 611914 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 617223 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 739039 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 749637 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 19500000 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 19700000 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 20600000 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 21200000 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 23100000 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 23200000 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 23500000 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 23700000 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 24500000 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 25000000 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 25900000 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 29100000 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 29900000 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 30200000 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 519969 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 552868 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 562985 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 608678 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 656222 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 667091 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 728320 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 732461 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 746648 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 747396 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 748280 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 755235 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 756025 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 851643 | Peak area normalized | female | normoglycemic | no neuropathy |